Telomeres and immune competency

Current Opinion in Immunology

Volumn 24, Issue 4, 2012, Pages 470-475

  Weng, Nan ping ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE;

AUTOIMMUNE DISEASE; B LYMPHOCYTE; BONE MARROW; CANCER RISK; CELL DIVISION; CELL LINEAGE; CELL PROLIFERATION; DIABETES MELLITUS; DISEASE ASSOCIATION; DYSKERATOSIS CONGENITA; GENE MUTATION; GENETIC SUSCEPTIBILITY; GRANULOCYTE; HUMAN; IMMUNE DEFICIENCY; IMMUNIZATION; IMMUNOCOMPETENCE; LEUKOCYTE; LIFESTYLE; LIVER CIRRHOSIS; LIVER FIBROSIS; LUNG FIBROSIS; MENTAL HEALTH; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; REVIEW; RHEUMATOID ARTHRITIS; T LYMPHOCYTE; TELOMERE HOMEOSTASIS; TELOMERE SHORTENING; VACCINATION;

ANIMALS; HUMANS; IMMUNE SYSTEM; TELOMERE; TELOMERE HOMEOSTASIS;

EID: 84865304245     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2012.05.001     Document Type: Review

References (49)

1. Blackburn E.H., Greider C.W., Szostak J.W. Telomeres and telomerase: the path from maize, Tetrahymena and yeast to human cancer and aging. Nat Med 2006, 12:1133-1138.
2. de Lange T. How telomeres solve the end-protection problem. Science 2009, 326:948-952.
3. Greider C.W. Telomeres and senescence: the history, the experiment, the future. Curr Biol 1998, 8:R178-R181.
4. Weng N.P., Levine B.L., June C.H., Hodes R.J. Human naive and memory T lymphocytes differ in telomeric length and replicative potential. Proc Natl Acad Sci USA 1995, 92:11091-11094.
5. Effros R.B., Boucher N., Porter V., Zhu X., Spaulding C., Walford R.L., Kronenberg M., Cohen D., Schachter F. Decline in CD28+ T cells in centenarians and in long-term T cell cultures: a possible cause for both in vivo and in vitro immunosenescence. Exp Gerontol 1994, 29:601-609.
6. Slagboom P.E., Droog S., Boomsma D.I. Genetic determination of telomere size in humans: a twin study of three age groups. Am J Hum Genet 1994, 55:876-882.
7. Rufer N., Brummendorf T.H., Kolvraa S., Bischoff C., Christensen K., Wadsworth L., Schulzer M., Lansdorp P.M. Telomere fluorescence measurements in granulocytes and T lymphocyte subsets point to a high turnover of hematopoietic stem cells and memory T cells in early childhood. J Exp Med 1999, 190:157-167.
8. Son N.H., Murray S., Yanovski J., Hodes R.J., Weng N. Lineage-specific telomere shortening and unaltered capacity for telomerase expression in human T and B lymphocytes with Age. J Immunol 2000, 165:1191-1196.
9. Armanios M. Syndromes of telomere shortening. Annu Rev Genomics Hum Genet 2009, 10:45-61.
10. Savage S.A., Bertuch A.A. The genetics and clinical manifestations of telomere biology disorders. Genet Med 2010, 12:753-764.
11. Calado R.T., Young N.S. Telomere diseases. N Engl J Med 2009, 361:2353-2365.
12. Sansoni P., Vescovini R., Fagnoni F., Biasini C., Zanni F., Zanlari L., Telera A., Lucchini G., Passeri G., Monti D., et al. The immune system in extreme longevity. Exp Gerontol 2008, 43:61-65.
13. Monteiro J., Batliwalla F., Ostrer H., Gregersen P.K. Shortened telomeres in clonally expanded CD28-CD8+ T cells imply a replicative history that is distinct from their CD28+CD8+ counterparts. J Immunol 1996, 156:3587-3590.
14. Kirwan M., Dokal I. Dyskeratosis congenita, stem cells and telomeres. Biochim Biophys Acta 2009, 1792:371-379.
15. Diaz de L.A., Cronkhite J.T., Katzenstein A.L., Godwin J.D., Raghu G., Glazer C.S., Rosenblatt R.L., Girod C.E., Garrity E.R., Xing C., Garcia C.K. Telomere lengths, pulmonary fibrosis and telomerase (TERT) mutations. PLoS ONE 2010, 5:e10680.
16. Calado R.T., Brudno J., Mehta P., Kovacs J.J., Wu C., Zago M.A., Chanock S.J., Boyer T.D., Young N.S. Constitutional telomerase mutations are genetic risk factors for cirrhosis. Hepatology 2011, 53:1600-1607.
17. Hartmann D., Srivastava U., Thaler M., Kleinhans K.N., N'kontchou G., Scheffold A., Bauer K., Kratzer R.F., Kloos N., Katz S.F., et al. Telomerase gene mutations are associated with cirrhosis formation. Hepatology 2011, 53:1608-1617.
18. Martinez-Delgado B., Yanowsky K., Inglada-Perez L., Domingo S., Urioste M., Osorio A., Benitez J. Genetic anticipation is associated with telomere shortening in hereditary breast cancer. PLoS Genet 2011, 7:e1002182.
19. Batista L.F., Pech M.F., Zhong F.L., Nguyen H.N., Xie K.T., Zaug A.J., Crary S.M., Choi J., Sebastiano V., Cherry A., et al. Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells. Nature 2011, 474:399-402.
20. Gadalla S.M., Cawthon R., Giri N., Alter B.P., Savage S.A. Telomere length in blood, buccal cells, and fibroblasts from patients with inherited bone marrow failure syndromes. Aging (Albany, NY) 2010, 2:867-874.
21. Weng N.P. Telomere and adaptive immunity. Mech Ageing Dev 2008, 129:60-66.
22. van B.D., Nanlohy N.M., Otto S., Plunkett F.J., Fletcher J.M., Akbar A.N. Progressive telomere shortening of Epstein-Barr virus-specific memory T cells during HIV infection: contributor to exhaustion?. J Infect Dis 2008, 198:1353-1357.
23. Menzel O., Migliaccio M., Goldstein D.R., Dahoun S., Delorenzi M., Rufer N. Mechanisms regulating the proliferative potential of human CD8+ T lymphocytes overexpressing telomerase. J Immunol 2006, 177:3657-3668.
24. Andrews N.P., Fujii H., Goronzy J.J., Weyand C.M. Telomeres and immunological diseases of aging. Gerontology 2010, 56:390-403.
25. Koetz K., Bryl E., Spickschen K., O'Fallon W.M., Goronzy J.J., Weyand C.M. T cell homeostasis in patients with rheumatoid arthritis. Proc Natl Acad Sci USA 2000, 97:9203-9208.
26. Fyhrquist F., Tiitu A., Saijonmaa O., Forsblom C., Groop P.H. Telomere length and progression of diabetic nephropathy in patients with type 1 diabetes. J Intern Med 2010, 267:278-286.
27. Testa R., Olivieri F., Sirolla C., Spazzafumo L., Rippo M.R., Marra M., Bonfigli A.R., Ceriello A., Antonicelli R., Franceschi C., et al. Leukocyte telomere length is associated with complications of type 2 diabetes mellitus. Diabet Med 2011, 28:1388-1394.
28. van de Berg P.J., Griffiths S.J., Yong S.L., Macaulay R., Bemelman F.J., Jackson S., Henson S.M., ten Berge I.J., Akbar A.N., Van Lier R.A. Cytomegalovirus infection reduces telomere length of the circulating T cell pool. J Immunol 2010, 184:3417-3423.
29. Lan Q., Cawthon R., Shen M., Weinstein S.J., Virtamo J., Lim U., Hosgood H.D., Albanes D., Rothman N. A prospective study of telomere length measured by monochrome multiplex quantitative PCR and risk of non-Hodgkin lymphoma. Clin Cancer Res 2009, 15:7429-7433.
30. Mirabello L., Garcia-Closas M., Cawthon R., Lissowska J., Brinton L.A., Peplonska B., Sherman M.E., Savage S.A. Leukocyte telomere length in a population-based case-control study of ovarian cancer: a pilot study. Cancer Causes Control 2010, 21:77-82.
31. Epel E.S., Blackburn E.H., Lin J., Dhabhar F.S., Adler N.E., Morrow J.D., Cawthon R.M. Accelerated telomere shortening in response to life stress. Proc Natl Acad Sci USA 2004, 101:17312-17315.
32. Damjanovic A.K., Yang Y., Glaser R., Kiecolt-Glaser J.K., Nguyen H., Laskowski B., Zou Y., Beversdorf D.Q., Weng N.P. Accelerated telomere erosion is associated with a declining immune function of caregivers of Alzheimer's disease patients. J Immunol 2007, 179:4249-4254.
33. Wolkowitz O.M., Mellon S.H., Epel E.S., Lin J., Dhabhar F.S., Su Y., Reus V.I., Rosser R., Burke H.M., Kupferman E., et al. Leukocyte telomere length in major depression: correlations with chronicity, inflammation and oxidative stress - preliminary findings. PLoS ONE 2011, 6:e17837.
34. Entringer S., Epel E.S., Kumsta R., Lin J., Hellhammer D.H., Blackburn E.H., Wust S., Wadhwa P.D. Stress exposure in intrauterine life is associated with shorter telomere length in young adulthood. Proc Natl Acad Sci USA 2011, 108:E513-E518.
35. Diaz V.A., Mainous A.G., Everett C.J., Schoepf U.J., Codd V., Samani N.J. Effect of healthy lifestyle behaviors on the association between leukocyte telomere length and coronary artery calcium. Am J Cardiol 2010, 106:659-663.
36. Buxton J.L., Walters R.G., Visvikis-Siest S., Meyre D., Froguel P., Blakemore A.I. Childhood obesity is associated with shorter leukocyte telomere length. J Clin Endocrinol Metab 2011, 96:1500-1505.
37. Puterman E., Lin J., Blackburn E., O'Donovan A., Adler N., Epel E. The power of exercise: buffering the effect of chronic stress on telomere length. PLoS ONE 2010, 5:e10837.
38. Armanios M., Alder J.K., Parry E.M., Karim B., Strong M.A., Greider C.W. Short telomeres are sufficient to cause the degenerative defects associated with aging. Am J Hum Genet 2009, 85:823-832.
39. Leslie M. Cell biology. Are telomere tests ready for prime time?. Science 2011, 332:414-415.
40. Eisenstein M. Telomeres: all's well that ends well. Nature 2011, 478:S13-S15.
41. Aubert G., Lansdorp P.M. Telomeres and aging. Physiol Rev 2008, 88:557-579.
42. Nordfjall K., Svenson U., Norrback K.F., Adolfsson R., Lenner P., Roos G. The individual blood cell telomere attrition rate is telomere length dependent. PLoS Genet 2009, 5:e1000375.
43. Ehrlenbach S., Willeit P., Kiechl S., Willeit J., Reindl M., Schanda K., Kronenberg F., Brandstatter A. Influences on the reduction of relative telomere length over 10 years in the population-based Bruneck Study: introduction of a well-controlled high-throughput assay. Int J Epidemiol 2009, 38:1725-1734.
44. Maecker H.T., McCoy J.P., Nussenblatt R. Standardizing immunophenotyping for the Human Immunology Project. Nat Rev Immunol 2012, 12:191-200.
45. Fauce S.R., Jamieson B.D., Chin A.C., Mitsuyasu R.T., Parish S.T., Ng H.L., Kitchen C.M., Yang O.O., Harley C.B., Effros R.B. Telomerase-based pharmacologic enhancement of antiviral function of human CD8+ T lymphocytes. J Immunol 2008, 181:7400-7406.
46. Di Mitri D., Azevedo R.I., Henson S.M., Libri V., Riddell N.E., Macaulay R., Kipling D., Soares M.V., Battistini L., Akbar A.N. Reversible senescence in human CD4+CD45RA+. J Immunol 2011, 187:2093-2100.
47. Wherry E.J. T cell exhaustion. Nat Immunol 2011, 12:492-499.
48. Bouree P. Immunity and immunization in elderly. Pathol Biol (Paris) 2003, 51:581-585.
49. Corti D., Voss J., Gamblin S.J., Codoni G., Macagno A., Jarrossay D., Vachieri S.G., Pinna D., Minola A., Vanzetta F., et al. A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins. Science 2011, 333:850-856.